Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.11.5345

Notch Inhibitor: a Promising Carcinoma Radiosensitizer  

Yu, Shu-Dong (Department of Otolaryngology, Qianfoshan Hospital Affiliated to Shandong University)
Liu, Fen-Ye (Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong University)
Wang, Qi-Rong (Department of Otolaryngology, Qianfoshan Hospital Affiliated to Shandong University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.11, 2012 , pp. 5345-5351 More about this Journal
Abstract
Radiotherapy is an important part of modern cancer management for many malignancies, and enhancing the radiosensitivity of tumor cells is critical for effective cancer therapies. The Notch signaling pathway plays a key role in regulation of numerous fundamental cellular processes. Further, there is accumulating evidence that dysregulated Notch activity is involved in the genesis of many human cancers. As such, Notch inhibitors are attractive therapeutic agents, although as for other anticancer agents, they exhibit significant and potential side effects. Thus, Notch inhibitors may be best used in combination with other agents or therapy. Herein, we describe evidence supporting the use of Notch inhibitors as novel and potent radiosensitizers in cancer therapy.
Keywords
Notch inhibitor; radiotherapy; radiosensitizer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kuhnert F, Kirshner JR, Thurston G (2011). Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc Cell, 3, 20.   DOI
2 Kurrey NK, Jalgaonkar SP, Joglekar AV, et al (2009). Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells, 27, 2059-68.   DOI   ScienceOn
3 Kvols LK (2005). Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med, 46, S187-90.
4 Lagadec C, Vlashi E, Della DL, Dekmezian C, Pajonk F (2012). Radiation-induced reprogramming of breast cancer cells. Stem Cells, 30, 833-44.   DOI   ScienceOn
5 Lai EC (2004). Notch signaling: control of cell communication and cell fate. Development, 131, 965-73.   DOI
6 Lee SF, Srinivasan B, Sephton CF, et al (2011). Gammasecretase-regulated proteolysis of the Notch receptor by mitochondrial intermediate peptidase. J Biol Chem, 286, 27447-53.   DOI
7 Li C, Zhang Y, Lu Y, et al (2011). Evidence of the cross talk between Wnt and Notch signaling pathways in non-smallcell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines. J Cancer Res Clin Oncol, 137, 771-8.   DOI
8 Lin H, Xiong W, Zhang X, et al (2011). Notch-1 activationdependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep, 26, 925-30.
9 Lin J, Zhang XM, Yang JC, Ye YB, Luo SQ (2010). Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Arch Med Res, 41, 519-29.   DOI
10 Lin JT, Chen MK, Yeh KT, et al (2010). Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol, 17, 2976-83.   DOI
11 Lin L, Fuchs J, Li C, et al (2011). STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH/CD133 stem cell-like human colon cancer cells. Biochem Biophys Res Commun, 416, 246-51.   DOI   ScienceOn
12 Lino MM, Merlo A, Boulay JL (2010). Notch signaling in glioblastoma: a developmental drug target. BMC Med, 8, 72.   DOI
13 Liu SK, Bham SA, Fokas E, et al (2011). Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst, 103, 1778-98.   DOI
14 Maliekal TT, Bajaj J, Giri V, Subramanyam D, Krishna S (2008). The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene, 27, 5110-14.   DOI
15 McAllister SS, Weinberg RA (2010). Tumor-host interactions: a far-reaching relationship. J Clin Oncol, 28, 4022-8.   DOI
16 Mihatsch J, Toulany M, Bareiss PM, et al (2011). Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro. Radiother Oncol, 99, 300-6.   DOI
17 Mori M, Miyamoto T, Yakushiji H, et al (2012). Effects of N-[N-(3, 5-difluorophenacetyl-L: -alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells. Hum Cell, 25, 9-15.   DOI
18 Morrison R, Schleicher SM, Sun Y, et al (2011). Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol, 2011, 941876.
19 Nickoloff BJ, Osborne BA, Miele L (2003). Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene, 22, 6598-608.   DOI   ScienceOn
20 Nam Y, Aster JC, Blacklow SC (2002). Notch signaling as a therapeutic target. Curr Opin Chem Biol, 6, 501-9.   DOI   ScienceOn
21 Noguera-Troise I, Daly C, Papadopoulos NJ, et al (2006). Blockade of Dll4 inhibits tumour growth by promoting nonproductive angiogenesis. Nature, 444, 1032-7.   DOI
22 Nygren P, Glimelius B (2001). The Swedish Council on Technology Assessment in Health Care (SBU) report on Cancer Chemotherapy--Project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation. Acta Oncol, 40, 155-65.   DOI
23 Ordentlich P, Lin A, Shen CP, et al (1998). Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol, 18, 2230-39.   DOI
24 Phillips TM, McBride WH, Pajonk F (2006). The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst, 98, 1777-85.   DOI   ScienceOn
25 Piao LS, Hur W, Kim TK, et al (2012). CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett, 315, 129-37.   DOI   ScienceOn
26 Purow B (2009). Notch inhibitors as a new tool in the war on cancer: a pathway to watch, Curr Pharm Biotechnol. Curr Pharm Biotechnol, 10, 154-60.   DOI
27 Purow B (2012). Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol, 727, 305-19.   DOI
28 Ramakrishnan V, Ansell S, Haug J, et al (2012). MRK003, a gamma-secretase inhibitor exhibits promising in vitro preclinical activity in multiple myeloma and non-Hodgkin's lymphoma. Leukemia, 26, 340-8.   DOI
29 Pyo H, Choy H, Amorino GP, et al (2001). A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res, 7, 2998-3005.
30 Qi R, An H, Yu Y, et al (2003). Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res, 63, 8323-9.
31 Rasul S, Balasubramanian R, Filipovic A, et al (2009). Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer, 100, 1879-88.   DOI
32 Reichert S, Rodel C, Mirsch J, et al (2011). Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma. Radiother Oncol, 101, 51-8.   DOI
33 Searfoss GH, Jordan WH, Calligaro DO, et al (2003). Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J Biol Chem, 278, 46107-16.   DOI
34 Sethi N, Dai X, Winter CG, Kang Y (2011). Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell, 19, 192-205.   DOI
35 Sikandar SS, Pate KT, Anderson S, et al (2010). NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res, 70, 1469-78.   DOI   ScienceOn
36 Strosberg JR, Yeatman T, Weber J, et al (2012). A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer, 48, 997-1003.   DOI
37 Spalding AC, Lawrence TS (2006). New and emerging radiosensitizers and radioprotectors. Cancer Invest, 24, 444-56.   DOI
38 Squatrito M, Brennan CW, Helmy K, et al (2010). Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell, 18, 619-29.   DOI
39 Sriuranpong V, Borges MW, Ravi RK, et al (2001). Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res, 61, 3200-5.
40 Suwanjunee S, Wongchana W, Palaga T (2008). Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling. Anticancer Drugs, 19, 477-86.   DOI
41 Szumiel I (2008). Intrinsic radiation sensitivity: cellular signaling is the key. Radiat Res, 169, 249-58.   DOI
42 Teimourian S, Jalal R, Sohrabpour M, Goliaei B (2006). Downregulation of Hsp27 radiosensitizes human prostate cancer cells. Int J Urol, 13, 1221-5.   DOI   ScienceOn
43 Tien AC, Rajan A, Bellen HJ (2009). A Notch updated. J Cell Biol, 184, 621-9.   DOI
44 Tsuyada A, Chow A, Wu J, et al (2012). CCL2 mediates crosstalk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res, 72, 2768-79 .   DOI
45 Wang J, Wakeman TP, Lathia JD, et al (2010). Notch promotes radioresistance of glioma stem cells. Stem Cells, 28, 17-28.
46 Wei P, Walls M, Qiu M, et al (2010). Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther, 9, 1618-28.   DOI
47 Wang M, Li JT, Zeng YX, Hou JH, Lin QQ. (2005). Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma. Ai Zheng, 24, 1230-4.
48 Wang Z, Li Y, Banerjee S, Sarkar FH (2008). Anticancer Res. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res, 28, 3621-30.
49 Wang Z, Li Y, Banerjee S, Sarkar FH (2009). Emerging role of Notch in stem cells and cancer. Cancer Lett, 279, 8-12.   DOI
50 Whitehead J, Thygesen H, Jaki T, et al (2012). A novel Phase I/ IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer. Stat Med, 31, 1931-43 .   DOI
51 Woodward WA, Chen MS, Behbod F, et al (2007). WNT/betacatenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A, 104, 618-23.   DOI
52 Wu Y, Cain-Hom C, Choy L, et al (2010). Therapeutic antibody targeting of individual Notch receptors. Nature, 464, 1052-7.   DOI
53 Xu X, Zhao Y, Xu M, et al (2011). Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. Med Oncol, 28, S483-9.   DOI
54 Yeung TM, Gandhi SC, Bodmer WF (2011). Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci U S A, 108, 4382-7.   DOI
55 Zhang AL, Russell PJ, Knittel T, Milross C (2007). Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Prostate, 67, 1630-40.   DOI
56 Yu J, Liu F, Sun M, Sun Z, Sun S (2011). Enhancement of radiosensitivity and the potential mechanism on human esophageal carcinoma cells by tetrandrine. Cancer Biother Radiopharm, 26, 437-42.   DOI
57 Yu S, Zhang R, Liu F, et al (2011). Down-regulation of Notch signaling by a gamma-secretase inhibitor enhances the radiosensitivity of nasopharyngeal carcinoma cells. Oncol Rep, 26, 1323-8.
58 Zaidi S, McLaughlin M, Bhide SA, et al (2012). The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage. PLoS One, 7, e35436.   DOI
59 Zhang X, Komaki R, Wang L, Fang B, Chang JY (2008). Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res, 14, 2813-23.   DOI
60 Zhang XP, Zheng G, Zou L, et al (2008). Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol. Cell. Biochem. 307, 101-8.
61 Zhang Y, Li B, Ji ZZ Zheng PS. (2010). Notch1 regulates the growth of human colon cancers. Cancer. 116, 5207-18.   DOI
62 Zhang Y, Peng J, Zhang H, et al. (2010). Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg, 39, 157-66.
63 Zhen Y, Zhao S, Li Q, Li Y, Kawamoto K (2010). Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett, 292, 64-72.   DOI
64 Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB (2008). Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest, 118, 3660-70.   DOI
65 Allen TD, Rodriguez EM, Jones KD, Bishop JM (2011). Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 71, 6010-8.   DOI
66 Artavanis-Tsakonas S, Rand MD, Lake RJ (1999). Notch signaling: cell fate control and signal integration in development. Science, 284, 770-6.   DOI   ScienceOn
67 Bao S, Wu Q, McLendon RE, et al (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60.   DOI   ScienceOn
68 Bischoff P, Altmeyer A, Dumont F (2009). Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers. Expert Opin Ther Pat, 19, 643-62.   DOI
69 Brou C, Logeat F, Gupta N, et al (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell, 5, 207-16.   DOI
70 Canman CE, Lim DS, Cimprich KA, et al (1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science, 281, 1677-9.   DOI
71 Chen YW, Chen KH, Huang PI, et al (2010). Cucurbitacin I suppressed stem-like property and enhanced radiationinduced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Mol Cancer Ther, 9, 2879-92.   DOI
72 Chen F, Pisklakova A, Li M, et al (2011). Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma. Cell Oncol (Dordr), 34, 545-51.   DOI
73 Chen SM, Liu JP, Zhou JX, et al (2011). Suppression of the notch signaling pathway by gamma-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation. Cancer Lett, 306, 76-84.   DOI
74 Chen Y, Li D, Liu H, et al (2011). Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells. Cancer Biol Ther, 11, 14-21.   DOI
75 Cohen-Jonathan E, Toulas C, Ader I, et al (1999). The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS. Radiat Res, 152, 404-11.   DOI
76 Cook N, Frese KK, Bapiro TE, et al (2012). Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. J Exp Med, 209, 437-44.   DOI
77 Cooper JS, Ang KK (2005). Concomitant chemotherapy and radiation therapy certainly improves local control. Int J Radiat Oncol Biol Phys, 61, 7-9.   DOI
78 Czito BG, Willett CG, Bendell JC, et al (2006). Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol, 24, 656-62.   DOI
79 Dai L, He J, Liu Y, et al (2011). Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with gamma-secretase inhibitor. Proteomics, 11, 4529-40.   DOI
80 Debeb BG, Cohen EN, Boley K, et al (2012). Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res Treat, 134, 495-510.   DOI
81 Deorukhkar A, Krishnan S (2010). Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol, 80, 1904-14.   DOI   ScienceOn
82 Dextraze ME, Cecchini S, Bergeron F, et al (2009). Reaching for the other side: generating sequence-dependent interstrand cross-links with 5-bromodeoxyuridine and gamma-rays. Biochemistry, 48, 2005-11.   DOI
83 Diehn M, Cho RW, Lobo NA, et al (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature, 458, 780-3.   DOI   ScienceOn
84 Dotto GP (2008). Notch tumor suppressor function. Oncogene, 27, 5115-23.   DOI
85 Dufraine J, Funahashi Y, Kitajewski J (2008). Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene, 27, 5132-37.   DOI
86 Efimova EV, Liang H, Pitroda SP, et al (2009). Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol, 85, 421-31.   DOI
87 Ellisen LW, Bird J, West DC, et al (1991). TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell, 66, 649-61.   DOI
88 Fan X, Khaki L, Zhu TS, et al (2010). NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 28, 5-16.
89 Garber K (2007). Notch emerges as new cancer drug target. J. Natl. Cancer Inst, 99, 1284-85.   DOI
90 Gil J, Stembalska A, Pesz KA, Sasiadek MM. (2008). Cancer stem cells: the theory and perspectives in cancer therapy. J Appl Genet, 49, 193-9.   DOI
91 Gogineni VR, Nalla AK, Gupta R, et al (2011). Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells. Cancer Lett, 313, 64-75.   DOI   ScienceOn
92 Guo S, Liu M, Gonzalez-Perez RR (2011). Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta, 1815, 197-213.
93 Hajdu M, Kopper L, Sebestyen A (2010). Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas. Scand J Immunol, 71, 29-37.   DOI
94 Harrison H, Farnie G, Howell SJ, et al (2010). Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res, 70, 709-18.   DOI
95 He Z, Subramaniam D, Ramalingam S, et al (2011). Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. Am J Physiol Gastrointest Liver Physiol, 301, G929-37.   DOI
96 Heidelberger C, Griesbach L, Cruz O, Schnitzer RJ, Grunberg E. (1958). Effects of 5-fluorouridine and 5-fluoro-2'-deoxyuridine on transplanted tumors. Proc Soc Exp Biol Med, 97, 470-5.   DOI
97 Hellstrom M, Phng LK, Hofmann JJ, et al (2007). Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature, 445, 776-80.   DOI
98 Hirose H, Ishii H, Mimori K, et al (2010). Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptornegative breast tumors. Oncol Rep, 23, 35-43.
99 Hovinga KE, Shimizu F, Wang R, et al (2010). Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells, 28, 1019-29.   DOI
100 Hosoki A, Yonekura S, Zhao QL, et al (2012). Mitochondriatargeted superoxide dismutase (SOD2) regulates radiation resistance and radiation stress response in HeLa cells. J Radiat Res, 53, 58-71.   DOI
101 Iliopoulos D, Hirsch HA, Wang G, Struhl K (2011). Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci U S A, 108, 1397-402.   DOI
102 Jehn BM, Bielke W, Pear WS, Osborne BA (1999). Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. J Immunol, 162, 635-8.
103 Jiang L, Wu J, Chen Q, et al (2011). Notch1 expression is upregulated in glioma and is associated with tumor progression. J Clin Neurosci, 18, 387-90.   DOI
104 Kato Y, Yashiro M, Fuyuhiro Y, et al (2011). Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells. Anticancer Res, 31, 3369-75.
105 Keysar SB, Jimeno A (2010). More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther, 9, 2450-57.   DOI
106 Kotowski U, Heiduschka G, Brunner M, et al (2011). Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane. Strahlenther Onkol, 187, 575-80.   DOI
107 Krop I, Demuth T, Guthrie T, et al (2012). Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors. J Clin Oncol, 30, 2307-13 .   DOI